|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
|
EP0091539B2
(en)
|
1982-03-31 |
1996-11-27 |
Ajinomoto Co., Inc. |
Gene coding for interleukin-2 polypeptide, recombinant DNA carrying said gene, cell lines possessing the recombinant DNA,and method for producing interleukin-2 using said cells
|
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
|
US4892743A
(en)
|
1983-12-21 |
1990-01-09 |
Schering Corporation |
Novel hybrid interferon species
|
|
EP0165942A1
(en)
|
1983-12-23 |
1986-01-02 |
Monash University |
PRODUCTION OF HUMAN INTERFERON-$g(a)
|
|
AU594014B2
(en)
|
1984-03-21 |
1990-03-01 |
Research Corporation Technologies, Inc. |
Recombinant DNA molecules
|
|
US4810643A
(en)
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
JPS63500636A
(ja)
|
1985-08-23 |
1988-03-10 |
麒麟麦酒株式会社 |
多分化能性顆粒球コロニー刺激因子をコードするｄｎａ
|
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
|
US5116742A
(en)
|
1986-12-03 |
1992-05-26 |
University Patents, Inc. |
RNA ribozyme restriction endoribonucleases and methods
|
|
CA2004261A1
(en)
|
1988-12-01 |
1990-06-01 |
Charles T. Tackney |
Synthetic interleukin-6
|
|
US5225337A
(en)
|
1989-09-25 |
1993-07-06 |
Innovir Laboratories, Inc. |
Ribozyme compositions and methods for use
|
|
US5246921A
(en)
|
1990-06-26 |
1993-09-21 |
The Wistar Institute Of Anatomy And Biology |
Method for treating leukemias
|
|
US5780036A
(en)
|
1991-08-26 |
1998-07-14 |
The Scripps Research Institute |
Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus
|
|
ATE227118T1
(de)
|
1993-08-02 |
2002-11-15 |
Scripps Research Inst |
Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
|
|
SE9401709D0
(sv)
|
1994-05-18 |
1994-05-18 |
Mathilda Sjoeberg |
Improved alphavirus vectors for expression of heterologous DNA
|
|
US5792462A
(en)
|
1995-05-23 |
1998-08-11 |
University Of North Carolina At Chapel Hill |
Alphavirus RNA replicon systems
|
|
US6041252A
(en)
|
1995-06-07 |
2000-03-21 |
Ichor Medical Systems Inc. |
Drug delivery system and method
|
|
DE19712889A1
(de)
|
1997-03-27 |
1998-10-01 |
Bosch Gmbh Robert |
Verfahren und Vorrichtung zur Ermittlung einer den Systemdruck in einem Bremskreis beschreibenden Größe
|
|
WO1998043702A2
(en)
|
1997-04-03 |
1998-10-08 |
Iacob Mathiesen |
Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
US5873849A
(en)
|
1997-04-24 |
1999-02-23 |
Ichor Medical Systems, Inc. |
Electrodes and electrode arrays for generating electroporation inducing electrical fields
|
|
GB0023203D0
(en)
|
2000-09-21 |
2000-11-01 |
Isis Innovation |
Vaccination method
|
|
US6117660A
(en)
|
1997-06-10 |
2000-09-12 |
Cytopulse Sciences, Inc. |
Method and apparatus for treating materials with electrical fields having varying orientations
|
|
CA2294793A1
(fr)
|
1997-06-30 |
1999-01-14 |
Rhone-Poulenc Rorer S.A. |
Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
|
|
US5958060A
(en)
|
1998-01-02 |
1999-09-28 |
General Electric Company |
Method and apparatus for clock control and synchronization
|
|
EP2428250A1
(en)
|
1998-07-13 |
2012-03-14 |
Genetronics, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
|
US6319901B1
(en)
|
1998-10-15 |
2001-11-20 |
Ichor Medical Systems, Inc. |
Methods for prolonging cell membrane permeability
|
|
US20040213805A1
(en)
|
1999-10-12 |
2004-10-28 |
Verheije Monique Helene |
Deletions in arterivirus replicons
|
|
WO2002020721A2
(en)
|
2000-09-07 |
2002-03-14 |
University Of North Carolina At Chapel Hill |
Vectors derived from south african arbovirus no. 86
|
|
US6538922B1
(en)
|
2000-09-27 |
2003-03-25 |
Sandisk Corporation |
Writable tracking cells
|
|
HU230198B1
(hu)
|
2000-11-23 |
2015-10-28 |
Bavarian Nordic A/S |
Módosított Vacciniavírus Ankara-variáns
|
|
WO2002061113A2
(en)
|
2001-02-01 |
2002-08-08 |
The Johns Hopkins University |
Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation
|
|
CA2448066A1
(en)
|
2001-05-31 |
2002-12-12 |
Chiron Corporation |
Chimeric alphavirus replicon particles
|
|
ATE354260T1
(de)
|
2001-07-19 |
2007-03-15 |
Ericsson Telefon Ab L M |
Verfahren und vorrichtung für die lösung der nummernübertragbarkeit am ursprungsort
|
|
US7245963B2
(en)
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
US6912417B1
(en)
|
2002-04-05 |
2005-06-28 |
Ichor Medical Systmes, Inc. |
Method and apparatus for delivery of therapeutic agents
|
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
|
WO2004055161A2
(en)
|
2002-12-12 |
2004-07-01 |
The Board Of Regents Of The University Of Texas System |
Large scale production of packaged alphavirus replicons
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
PT1651666E
(pt)
|
2003-07-11 |
2009-08-28 |
Alphavax Inc |
Vacinas de citomegalovírus à base de alfavírus
|
|
US20050070700A1
(en)
|
2003-09-30 |
2005-03-31 |
Matthias Giese |
Equine arteritis virus vaccine
|
|
KR101261642B1
(ko)
|
2004-03-08 |
2013-05-06 |
아이커 메디칼 시스템스 인코포레이티드 |
치료 제제의 전기 매개식 이송을 위한 개선된 장치
|
|
PT1751289E
(pt)
|
2004-05-18 |
2009-03-31 |
Alphavax Inc |
Vectores de alfavirais derivados da tc-83, partículas e métodos
|
|
US20090104226A1
(en)
|
2004-05-21 |
2009-04-23 |
Novartis Vaccines And Diagnostics Inc. |
Alphavirus Vectors for Respiratory Pathogen Vaccines
|
|
AU2005327198B2
(en)
|
2004-07-09 |
2011-03-31 |
University Of North Carolina At Chapel Hill |
Viral adjuvants
|
|
EP2029747A4
(en)
|
2006-06-06 |
2011-01-05 |
Melbourne Health |
PROOF AND USE OF ANTIVIRAL RESISTANCE MUTATIONS
|
|
EP2062246A4
(en)
|
2006-08-18 |
2010-09-29 |
Univ North Carolina |
VACCINES AGAINST CHIMARICAL VIRUSES
|
|
AU2007313203B2
(en)
|
2006-10-17 |
2012-08-16 |
Vgx Pharmaceuticals, Llc |
Electroporation devices and methods of using same for electroporation of cells in mammals
|
|
EP2097538A4
(en)
|
2006-12-07 |
2011-11-30 |
Switchgear Genomics |
TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS
|
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Ｈｂｖ 백신 및 그의 제조 방법
|
|
DK2947149T3
(en)
|
2007-06-21 |
2018-06-06 |
Alphavax Inc |
ALPHAVIRUS REPLICATION PARTICLES FOR USE IN VACCINATION
|
|
US20110110974A1
(en)
|
2007-10-29 |
2011-05-12 |
Erik Depla |
Methods and kits for inducing a ctl response using a prime boost regimen
|
|
CA2770075C
(en)
|
2009-08-07 |
2021-08-24 |
Perrine Martin |
Composition for treating hbv infection
|
|
WO2011082388A2
(en)
|
2009-12-31 |
2011-07-07 |
Medigen, Inc . |
Infectious dna vaccines against chikungunya virus
|
|
PT3243526T
(pt)
|
2010-07-06 |
2020-03-04 |
Glaxosmithkline Biologicals Sa |
Distribuição de arn para despoletar múltiplas vias imunitárias
|
|
AU2011349464B2
(en)
|
2010-12-20 |
2016-07-07 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAS
|
|
US9403879B2
(en)
|
2011-02-11 |
2016-08-02 |
The Trustees Of The University Of Pennsylvania |
Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same
|
|
DK3473296T3
(da)
|
2011-06-28 |
2020-11-09 |
Inovio Pharmaceuticals Inc |
Minimalt invasiv dermal elektroporeringsenhed
|
|
TWI575070B
(zh)
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Ｈｂｖ聚合酶突變體
|
|
AU2013266496B2
(en)
*
|
2012-05-21 |
2018-08-09 |
The Regents Of The University Of California |
Generation of human iPS cells by a synthetic self- replicative RNA
|
|
US8961995B2
(en)
|
2012-09-20 |
2015-02-24 |
Uab Research Foundation |
Methods and compositions for alphavirus replicons
|
|
EP3178505B1
(en)
|
2012-12-13 |
2018-05-02 |
Panasonic Healthcare Holdings Co., Ltd. |
Medicament injection device
|
|
WO2014170493A2
(en)
|
2013-04-19 |
2014-10-23 |
Novartis Ag |
Alphavirus vector
|
|
AU2014310935B2
(en)
|
2013-08-21 |
2019-11-21 |
CureVac SE |
Combination vaccine
|
|
WO2016020538A1
(en)
|
2014-08-08 |
2016-02-11 |
Transgene Sa |
Hbv vaccine and antibody combination therapy to treat hbv infections
|
|
KR102586707B1
(ko)
|
2014-10-01 |
2023-10-11 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
항원 및 어쥬번트로서 인터류킨-21을 갖는 백신
|
|
PL3280729T3
(pl)
|
2015-04-08 |
2022-08-22 |
Novartis Ag |
Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19
|
|
DK3294326T3
(da)
|
2015-05-15 |
2021-05-31 |
Curevac Ag |
Prime-boost-regimer indbefattende indgivelse af mindst én mrna-konstruktion
|
|
JP7048482B2
(ja)
|
2015-08-03 |
2022-04-05 |
アメリカ合衆国 |
Ｂｒａｃｈｙｕｒｙ欠失変異体、Ｂｒａｃｈｙｕｒｙ欠失変異体をコードする非酵母ベクター、及びそれらの使用
|
|
NZ747635A
(en)
|
2016-03-28 |
2024-05-31 |
Ichor Medical Systems Inc |
Method and apparatus for delivery of therapeutic agents
|
|
WO2017176319A1
(en)
|
2016-04-06 |
2017-10-12 |
University Of Washington |
Therapeutic vaccine for hepatitis b virus (hbv) using the hbv core antigen
|
|
JP7250520B2
(ja)
|
2016-04-13 |
2023-04-03 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
組換えアルテリウイルスレプリコン系およびその使用
|
|
ES2993107T3
(en)
|
2016-10-17 |
2024-12-23 |
Janssen Pharmaceuticals Inc |
Recombinant virus replicon systems and uses thereof
|
|
JP7788787B2
(ja)
|
2016-12-05 |
2025-12-19 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
遺伝子発現増強のための組成物および方法
|
|
CN110612118B
(zh)
|
2017-06-05 |
2024-02-13 |
比科尔公司 |
用于引起针对hbv的免疫应答的病毒样粒子
|
|
CN117866990A
(zh)
|
2017-11-16 |
2024-04-12 |
华盛顿大学 |
使用HBV包膜蛋白的HBV PreS1和/或PreS2和/或S-HBsAg区域的治疗乙型肝炎病毒（HBV）的疫苗
|
|
EA202091513A1
(ru)
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
|
MA51311A
(fr)
|
2017-12-19 |
2020-10-28 |
Janssen Sciences Ireland Unlimited Co |
Vaccins contre le virus de l'hépatite b (vhb) et utilisations associées
|
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|